Algert Global LLC Atara Biotherapeutics, Inc. Transaction History

Algert Global LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $114,387 - $228,910	-13,553 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.7 - $19.89 $66,150 - $89,505	-4,500 Reduced 24.93%	13,553 $214,000
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $70,537 - $105,305	5,883 Added 48.34%	18,053 $323,000
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $156,871 - $201,778	12,170 New	12,170 $189,000
Q1 2020 May 13, 2020	SELL	$5.69 - $17.78 $169,231 - $528,812	-29,742 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$10.89 - $16.79 $323,890 - $499,368	29,742 New	29,742 $490,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $992M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.